• Radiation Oncology Journal
• /
• 제3권2호
• /
• pp.163-168
• /
• 1985

원발성 안구 흑색종은 20세 이상의 성인에서 가장 많이 발생되는 안주의 악성종양이지만 한국에서의 발생빈도는 그리 흔하지 않은 것으로 되어 있다. 안구 흑색종의 치료전에는 문진, 이학적검사, 기본적인 혈액상검사와, 특히 간, 폐, 골에 세심한 주의를 하여야 하며, 그래서 흉부 X-선과 LDH, SGPT, Transpeptidase를 포함한 간기능 검사 등을 시행하여야 하고 만약 임상적으로 증상이 있거나 위의 검사상 비정상적인 소견을 보일 매에는 전신뼈 스캔, 간-지 라 스캔을 시행하여야 한다. 일반적으로 악성 흑색종은 방사선 치료에 대해 치료효과가 나쁜 것으로 알려져 있지만 때로는 총 종양조사선량 $7,000\~8,000 cG/8\~9$주로 매우 빠른 종괴의 감소를 보여 주기도 한다. 그리하여 저자등은 외부방사선조사로 빠른 치료반응을 보인 원발성 안주 흑색종의 치료와 문헌고찰을 보고하는 바이다.

• Radiation Oncology Journal
• /
• 제2권1호
• /
• pp.115-122
• /
• 1984

Total 125 patinets with primary and metastatic Ewing's sarcoma were treated in various ways between 1963 to 1977. Patients were divided into 3 groups according to the treatment methods. Group 1 was nonprotocol patients with or without chemotherapy. Total 58 patients were entered. Group 1 was divided into 2 subgroups. 33 patients were treated locally without chemotherapy and 25 Patients were treated with local therapy and nonprotocol chemotherapy. Group 2 was treated with local therapy and plus T-2 regimen multiagent chemotherapy. 29 patients were entered. Group 3 was treated with local therapy and T-6 regimen multiagent chemotherapy. 38 patients were entered. Local treatments for primary tumor were surgery and/or radiation therapy. Radiation dose ranged between 2,000 and 8,000 rad. Patients with pulmonary metastases received bilateral pulmonary RT. Local recurrence rate was analyzed according to treatment groups and was $16.8\%$. Local 15 yr survival was $33\%$ and 8 yr survival of T-6 group was $64.9\%$. An analysis of time were pattern of recurrence of each group, and the correlation of with radiation dose with local recurrence done. This study concluded that intensive multiagent chemotherapy RT and/or surgery (T-6 regimen) reduced distant metastases, and produced significant increase in local control and survival.

• 천문학논총
• /
• 제30권2호
• /
• pp.295-296
• /
• 2015

This study deals with the generalization of the Elliptic Restricted Three-Body Problem (ER3BP) by considering the effects of radiation and oblate spheroid primaries. This may illustrate a gas giant exoplanet orbiting its host star with eccentric orbit. In the three dimensional case, this generalization may possess two additional equilibrium points ($L_{6,7}$, out-of-plane). We determine the existence of $L_{6,7}$ in ER3BP under the effects of radiation (bigger primary) and oblateness (small primary). We analytically derive the locations of $L_{6,7}$ and assume initial approximations of (${\mu}-1$, ${\pm}\sqrt{3A_2}$), where ${\mu}$ and $A_2$ are the mass parameter and oblateness factor, respectively. The fixed locations are then determined. Our results show that the locations of $L_{6,7}$ are periodic and affected by $A_2$ and the radiation factor ($q_1$).

• Radiation Oncology Journal
• /
• 제35권2호
• /
• pp.185-188
• /
• 2017

Primary liver tumor, especially hepatocellular carcinoma (HCC), is a common cause of cancer death worldwide. The incidence is generally higher in Asian countries than in western countries. Carcinogenesis of HCC is often associated with hepatitis viral infections. Current standard treatment of HCC is surgical resection or transplantation in patients with early stage disease. However, the patient with advanced stage disease, surgical resection is often limited. Sorafenib or other treatment modalities are not so effective as well. We report a case of unusual radiation super-sensitivity in advanced stage HCC, and review the literature.

• Radiation Oncology Journal
• /
• 제33권4호
• /
• pp.301-309
• /
• 2015

Purpose: To identify prognostic factors for disease progression and survival of patients with extracranial oligometastatic breast cancer (EOMBC), and to investigate the role of radiation therapy (RT) for metastatic lesions. Materials and Methods: We retrospectively reviewed the medical records of 50 patients who had been diagnosed with EOMBC following standard treatment for primary breast cancer initially, and received RT for metastatic lesions, with or without other systemic therapy between January 2004 and December 2008. EOMBC was defined as breast cancer with five or less metastases involving any organs except the brain. All patients had bone metastasis (BM) and seven patients had pulmonary, hepatic, or lymph node metastasis. Median RT dose applied to metastatic lesions was 30 Gy (range, 20 to 60 Gy). Results: The 5-year tumor local control (LC) and 3-year distant progression-free survival (DPFS) rate were 66.1% and 36.8%, respectively. High RT dose (${\geq}50Gy_{10}$) was significantly associated with improved LC. The 5-year overall survival (OS) rate was 49%. Positive hormone receptor status, pathologic nodal stage of primary cancer, solitary BM, and whole-lesion RT (WLRT), defined as RT whose field encompassed entire extent of disease, were associated with better survival. On analysis for subgroup of solitary BM, high RT dose was significantly associated with improved LC and DPFS, shorter metastasis-to-RT interval (${\leq}1month$) with improved DPFS, and WLRT with improved DPFS and OS, respectively. Conclusion: High-dose RT in solitary BM status and WLRT have the potential to improve the progression-free survival and OS of patients with EOMBC.

• Radiation Oncology Journal
• /
• 제3권1호
• /
• pp.19-28
• /
• 1985

Twenty-four cases of pituitary adenoma, 13 males and 11 females with the age ranging from 11 to 65 years, received radiation therapy(RT) on the pituitary area with 6MV linear accelerator during past 25 months at the Division of Radiation Therapy, Kangnam St. Mary's Hospital, Catholic Medical College. Of 24 cases of RT, 20 were postoperative and 4 primary. To evaluate the effect of RT, we analysed the alteration of the endocrinologic tests, neurologic abnormalities, major clinical symptoms, endocrinologic changes and improvement in visual problems after RT. The results were as follows ; 1. Major clinical symptoms were headache, visual defects, diabetes insipidus, hypogonadisms and general weakness in decreasing order of frequency. 2. All but the one with Nelson's syndrome showed abnormal neuroradiologic changes in the sella turcica with an invasive tumor mass around supra· and para-sellar area. 3. Endocrinological classifications of the patient were 11 prolactinoma, 4 growth hormone -secreting tumors, 3 ACTH-secreting tumors consisting of one Cushing's disease and two Nelson's syndrome, and 6 nonfunctioning tumors. 4. Eleven of 14 patients, visual problems were improved after treatment but remaining 3 were unchanged. 5. Seven of 11 prolactinomas returned to normal hormonal level after postoperative and primary RT and 3 patients are being treated with bromocriptine (BMCP) but one lost case. 6. Two of 4 growth hormone·secreting tumor returned to normal level after RT but the remaining 2 are being treated with BMCP, as well.

• Radiation Oncology Journal
• /
• 제7권2호
• /
• pp.235-245
• /
• 1989

Rhabdomyosarcoma is a highly malignant soft tissue sarcoma that can arise in any site of the body containing striated muscle or its mesenchymal analgae. It is the most common childhood sarcoma with two peak age frequencies, one at ages 2 to 6, and one in the adolescence. The site, stage and extent of disease, and pathologic characteristics of the tumor contribute to prognostic factors that influence therapeutic decisions. The results of treatment of 52 patients with rhabdomyosarcoma, who were treated at Department of Radiation Oncology, Yonsei University College of Medicine, Yosei Cancer Center from 1976 to 1987 were retrospectively analyzed. The most frequent clinical group and primary sites were IRS group III (57.7%) and head and neck (42.3%) including orbit (11.5%) and parameningeal region(13.5%). The overall and disease free 5 year survival rate of eligible 41 patients were 31.7%, 29.3%, respectively. The complete remission (CR) rate was 50% in clinical group III and 0% in IV. Primary tumors of the orbit, clinical group 1 and embryonal subtype had the best prognosis. The Survival rate was improved by additiion of chemotherapy to operation and radiation therapy.

• 한국방사선학회논문지
• /
• 제12권5호
• /
• pp.549-555
• /
• 2018

방사선 영상 기술은 피사체의 조성 및 두께에 따라 변화되는 X선의 흡수계수 차이를 기반으로 형성되는 대조도를 영상화하는 기술로서 영상 검출기에 입사하는 1차선 뿐 만 아니라 산란선이 영상 품질에 큰 영향을 미친다. 이에 본 연구에서는 피사체 두께, 조사야 변화에 따라 발생하는 산란선이 영상 품질에 미치는 영향을 고찰하고자 몬테카를로 시뮬레이션을 통하여 FSR 및 SPR 분석을 수행하였다. 연구 결과, 피사체 두께에 따른 FSR은 최대 15.3%p, SPR은 2.00 ~ 4.54로 분석되었으나, 조사야 변화에 대해서는 일정한 값을 유지하는 것으로 분석되었다. 이러한 결과를 바탕으로 피사체 두께는 영상 품질에 영향을 미치는 인자로서 고려되어야 하지만, 조사야는 영상 품질에 영향을 미치지 못하는 인자임을 검증하였다. 이러한 본 연구 결과는 영상 품질 개선을 위한 산란선에 대한 기초 자료로서 활용할 수 있을 것으로 사료된다.

• Radiation Oncology Journal
• /
• 제28권4호
• /
• pp.224-230
• /
• 2010

목적: 본 연구에서는 콘빔 CT에서 산란선 제거를 위한 aft-multple-slit (AMS) 시스템을 설계하였다. 예비 연구로서 본 시스템의 효용성을 검증하기 위해 MC 시뮬레이션을 수행하였다. 대상 및 방법: 가상 시뮬레이션은 산란선과 산란선+일차선을 계산할 수 있는 MCNPX의 radiography tally 5를 이용하였다. AMS는 빔의 발산성을 고려한 각이 동일한 아크 형태이고, 길이 방향에서의 산란선을 막는다. AMS의 효용성을 위한 평가는 AMS를 사용하지 않았을 때의 일차선과 산란선을 비교함으로써 수행되었다. 2D projection 영상을 얻기 위해 전체의 AMS는 한번의 캔트리 회전 후 AMS에 의해 가려진 부분의 영상 획득을 위해 다시 한 번 회전하는 구조이다. 결과: 일차선의 2D projection 영상은 모든 AMS의 폭에서 그리고 AMS를 사용하지 않았을 때에도 동일하였으나 일차선+산란선의 2D projection 영상은 slit의 폭에 따라 결과가 변했다. Slit의 폭을 5 mm, 10 mm, 15 mm, 20 mm로 하였을 때 평균 산란성 제거율은 29%, 15%, 9%, 8%였다. 결론: 본 연구에서는 AMS를 이용한 콘빔 CT의 산란선 제거 효과를 평가하였다. MC 시뮬레이션을 이용한 본 시스템의 사전 연구에서는 상당한 산란선 제거 효과를 보여주었다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권16호
• /
• pp.7025-7029
• /
• 2015

Background: The optimal sequence and extent of multimodality therapy remains to be defined for extrapulmonary small cell carcinoma because of its rarity. The purpose of our study was to assess the response to neoadjuvant chemotherapy followed by chemoradiation/radiation in patients with extrapulmonary small cell carcinoma. Materials and Methods: Four consecutively diagnosed patients were included in this study. The primary tumor site was oropharynx in three patients and esophagus in one. The patients with the limited disease were treated with chemotherapy followed by concurrent chemoradiation (n=2) or radiotherapy (n=1). The patient with the extensive disease with the primary site in vallecula was treated with chemotherapy and palliative radiotherapy to the metastatic site. Results: The median follow-up was 22.5 months (range, 8-24 months). Three patients with the limited disease (base of tongue, n=2; esophagus, n=1) were in complete remission. The patient with the extensive disease died of loco-regional tumor progression at 8 months from the time of diagnosis. Conclusions: The combination of chemotherapy and radiotherapy is the preferred therapeutic approach for patients with extrapulmonary small cell carcinoma. Induction chemotherapy followed by concurrent chemoradiation or radiation provides a good loco-regional control in patients with limited disease.